Recruiting NCT05077124

Safe and Timely Antithrombotic Removal (STAR) Registry

Trial Parameters

Condition Hemorrhage, Surgical

Sponsor CytoSorbents, Inc

Study Type OBSERVATIONAL

Phase N/A

Enrollment 1,000

Sex ALL

Min Age 18 Years

Max Age N/A

Start Date 2021-09-30

Completion 2025-09-30

All Conditions

Hemorrhage, Surgical Hemorrhage Postoperative Blood Loss, Surgical Blood Loss, Postoperative

Interventions

CytoSorb

Brief Summary

This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents.

Eligibility Criteria

Inclusion Criteria: * CytoSorb utilization for antithrombotic removal * Informed consent for prospective registry participation Exclusion Criteria: • Use of CytoSorb for purpose other than antithrombotic removal

Related Trials

NCT05077124

Safe and Timely Antithrombotic Removal (STAR) Registry

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE HEMORRHAGE, SURGICAL TRIALS